FDA OKs Drug Patch to Treat Parkinson's - May 10, 2007
" WASHINGTON (AP) -- The treatment options for patients with early Parkinson's expanded Wednesday with the approval of a new drug in patch form -- a first for medicines to treat symptoms of the disease. "
" The once-daily Neupro patch contains a drug called rotigotine, which has not been sold before in the United States, the Food and Drug Administration said. The drug patch, made by Schwarz Pharma AG, is the first for the treatment of symptoms of Parkinson's disease. "
" Parkinson's disease results from the loss of dopamine-producing brain cells. Dopamine is crucial for the communication between cells that control muscle movement, which explains the trembling commonly seen in Parkinson's patients. "
" The most common side effects for Neupro include skin reactions at the patch site, dizziness, nausea, vomiting, drowsiness ... read the whole article
comments:(log in to vote on this article or comment on it)